Editorial
doi: 10.1002/art.24875.
Atherothrombotic comorbidity in the rheumatic diseases. The evidence becomes clearer. What should clinicians do?
- PMID: 19790116
- DOI: 10.1002/art.24875
Item in Clipboard
Editorial
Atherothrombotic comorbidity in the rheumatic diseases. The evidence becomes clearer. What should clinicians do?
Arthritis Rheum.
.
No abstract available
Comment on
-
Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study.Arthritis Rheum. 2009 Oct 15;61(10):1396-402. doi: 10.1002/art.24537. Arthritis Rheum. 2009. PMID: 19790130 Free PMC article.
Similar articles
-
Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe.Heart. 2011 Apr;97(8):660-7. doi: 10.1136/hrt.2010.213710. Epub 2011 Feb 25. Heart. 2011. PMID: 21357372
-
Rheumatologic rehabilitation: the great expectation for rheumatic patients.Reumatismo. 2012 Mar 16;64(1):1-6. doi: 10.4081/reumatismo.2012.1. Reumatismo. 2012. PMID: 22472777 No abstract available.
-
[Atherosclerosis inflammation and rheumatic diseases].Acta Reumatol Port. 2008 Jan-Mar;33(1):9-11. Acta Reumatol Port. 2008. PMID: 18344917 Portuguese. No abstract available.
-
Malignancy as a comorbidity in rheumatic diseases.Rheumatology (Oxford). 2013 Jan;52(1):5-14. doi: 10.1093/rheumatology/kes189. Epub 2012 Jul 23. Rheumatology (Oxford). 2013. PMID: 22829694 Review.
-
[Atherothrombosis in rheumatic diseases: pathogenesis analysis].Ter Arkh. 1998;70(9):92-5. Ter Arkh. 1998. PMID: 9821241 Review. Russian. No abstract available.
Cited by
-
The effect of regular colchicine treatment on biomarkers related with vascular injury in newly diagnosed patients with familial Mediterranean fever.Inflammation. 2012 Jun;35(3):1191-7. doi: 10.1007/s10753-012-9428-7. Inflammation. 2012. PMID: 22258906
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
